Related Experiment Videos
["Bronze baby" syndrome]
S Rodot1, J P Lacour, C Dageville
1Service de Dermatologie, Hôpital Pasteur, Nice.
Insights
Bronze baby syndrome is a rare complication of phototherapy for neonatal jaundice. This condition, caused by cholestasis, leads to a grey-brown skin discoloration in infants, which resolves after treatment.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Dermatology
Background:
- Neonatal jaundice is common, often treated with phototherapy.
- Bronze baby syndrome is a rare, adverse reaction to phototherapy.
- It is associated with impaired liver function, specifically cholestasis.
Observation:
- A premature infant developed a grey-brown skin discoloration during phototherapy for hemolytic jaundice.
- The infant had Rhesus incompatibility and cholestasis due to thick bile.
- This coloration is linked to the accumulation of unexcreted photoproducts.
Findings:
- The premature infant's bronze coloration was attributed to cholestasis and phototherapy.
- Abnormal photoproduct accumulation caused the skin discoloration.
- The condition resolved spontaneously after phototherapy cessation.
Implications:
- Identifying the underlying liver disease is crucial for prognosis.
- Bronze baby syndrome highlights the importance of monitoring liver function during phototherapy.
- This case underscores the need for further research into phototherapy complications.
Abstract:
"Bronze baby" syndrome is a rare complication of phototherapy for neonatal jaundice occurring due to modified liver function, particularly cholestasis, of various origins. We report a case which occurred in a premature infant who developed a grey-brown coloration during phototherapy. The infant had haemolytic jaundice due to Rhesus incompatibility complicated by cholestasis of thick bile fluid. Abnormal accumulation of unexcreted photoproducts due to the cholestasis appeared to be the cause of the bronze coloration. The clinical course was favourable and the skin coloration returned to normal a few weeks after the end of the phototherapy. It is essential to identify the underlying liver disease in order to determine the prognosis of this syndrome.